By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...